Clinical Trials Logo

Clinical Trial Summary

Clinical test (essay) randomized to evaluate the toxicity adherence and efficiency of the chemoprophylaxis of tuberculosis (TB) in subjects with Diabetes Mellitus (DM) and latent TB. (600 subjects followed(continued) by 15 months). 3rd stage. Patients with DM and TB will be included to determine if the strict control of the dm achieved in clinics of the first level of attention improves clinical manifestations of tb, the result of treatment, the frequency of relapses, the mortality and the transmission to contacts.

Elispot will be used to measure TB development and the time for the bacteriological negativization and biochemical parameters as well as tuberculin skin test (TST), quantiferon, in contacts. (160 patients 600 contacts followed(continued) for 12 months). additional there will be evaluated the socioeconomic impact of both diseases and his(her) control. 1er year: transverse study and recruitment years 2 and 3 participants' follow-ups in clinical tests(essays).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03498534
Study type Interventional
Source Instituto Nacional de Salud Publica, Mexico
Contact
Status Withdrawn
Phase Phase 4
Start date September 2012
Completion date December 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Not yet recruiting NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Active, not recruiting NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT00339482 - Prospective Studies of the Natural History of Diabetes Mellitus and Its Complications in the Gila River Indian Community
Recruiting NCT03285308 - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Phase 3
Recruiting NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03359629 - Spectrophon LTD Glucometry Monitor Accuracy N/A
Completed NCT03238898 - Botulinum Toxin for Cramps in Diabetic Neuropathy Phase 2
Recruiting NCT03112343 - Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment N/A
Completed NCT00382564 - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease N/A
Not yet recruiting NCT02042339 - Hyperbaric Oxygenation in Diabetic Ulcer Phase 3
Not yet recruiting NCT03607617 - ASCEND: ApproacheS to CHC ImplEmeNtation of SDH Data Collection and Action
Not yet recruiting NCT03666923 - A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) Phase 1
Not yet recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Not yet recruiting NCT03462420 - Physiotherapy Program for Managing Adhesive Capsulitis in Patients With Diabetes N/A
Not yet recruiting NCT03274362 - Headspace Mindfulness App Trial N/A
Recruiting NCT03352674 - Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients Phase 2